Laboratorios Rubio

Laboratorios Rubio

Pharmaceutical solutions specializing in niche therapeutic areas, enhancing patient care with tailored treatments.

HQ location
Castellbisbal, Spain
Launch date
Employees
Company register number
A08222465
Recent deals
  • Edit
DateInvestorsAmountRound
*

€4.0m

Debt
Total Funding000k

Financials

Estimates*

Get premium to view all results
Edit
Revenues, earnings & profits over time
EUR20222023
Revenues00000000
% growth-22 %
EBITDA00000000
Profit00000000
% profit margin5 %5 %
EV00000000
EV / revenue00.0x00.0x
EV / EBITDA00.0x00.0x
R&D budget00000000

Source: Company filings or news article

Notes (0)
More about Laboratorios Rubio
Made with AI
Edit

Laboratorios Rubio operates in the pharmaceutical industry, focusing on developing and manufacturing specialized medications for niche therapeutic areas. The company serves healthcare professionals and patients by providing tailored treatments that address specific medical needs. Operating primarily in the European market, Laboratorios Rubio employs a business model centered around research and development, production, and distribution of pharmaceutical products. Revenue is generated through the sale of these specialized medications to healthcare providers and institutions. The company is committed to maintaining compliance with data protection laws, ensuring responsible handling of personal information. Key aspects of their operations include a focus on patient care, adherence to regulatory standards, and a commitment to quality in pharmaceutical manufacturing.

Keywords: pharmaceuticals, niche, therapeutic, patient care, healthcare, European market, R&D, compliance, manufacturing, quality.

Analytics
Unlock the full power of analytics with a premium account
Track company size and historic growth
Track team composition and strength
Track website visits and app downloads

Tech stack

Group
Tech stackLearn more about the technologies and tools that this company uses.
Book a Demo

Investments by Laboratorios Rubio

Edit
OWL Metabolomics
ACQUISITION by Laboratorios Rubio Jun 2023